Page 6 - Keith Berman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CEO Charged With Fraud in 15-Second COVID Test Scheme On 12/18/20 at 5:27 PM EST Keith Berman, the CEO of Decision Diagnostics Corporation (DECN), was indicted for securities fraud after investors purchased stock in his company hoping to profit from a revolutionary COVID-19 test which, in reality, did not exist. Berman claimed that his company had developed a test that could detect COVID-19 from a drop of blood within 15 seconds. Berman told investors via press releases that the test would be ready for the commercial market in the summer of 2020 and raised millions of dollars in funds to supp...

NEW YORK, Dec 17 (Reuters) - The U.S. Securities and Exchange Commission sued Decision Diagnostics Corp and its chief executive for allegedly misleading investors by promising the biotechnology company could test for COVID-19 with a finger-prick of blood and provide accurate results in less than one minute. In a complaint filed on Thursday in Manhattan federal court, the SEC said Chief Executive Keith Berman made materially false statements between March and June about what he claimed was his company's blood testing kit, and its efforts to obtain Food and Drug Administration approval for its ...

SEC sues California biotech company for misleading investors about COVID-19 tests 12/17/2020 | 05:00pm EDT Send by mail : Message : Required fields NEW YORK (Reuters) - The U.S. Securities and Exchange Commission sued Decision Diagnostics Corp and its chief executive for allegedly misleading investors by promising the biotechnology company could test for COVID-19 with a finger-prick of blood and provide accurate results in less than one minute. In a complaint filed on Thursday in Manhattan federal court, the SEC said Chief Executive Keith Berman made materially false statements between Ma...

Decision Diagnostics Corp.: DECN Provides Testing Update for US, Korea and XPRIZE With Plans for Walk-in Donor Study for at-Home GenViro! Saliva Swift :10 Test Kit DECN plans 150 patient donor study to complete its at-home testing kit EUA LOS ANGELES, CA / ACCESSWIRE / December 16, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co, a leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters through its subsidiary Pharma Tech Solutions, Inc., as well as the designer and manufacturer of the GenViro! Covid-19 ...